nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—Gemfibrozil—coronary artery disease	0.095	0.436	CbGbCtD
Triamterene—CYP1A2—Clopidogrel—coronary artery disease	0.0824	0.378	CbGbCtD
Triamterene—CYP1A2—Losartan—coronary artery disease	0.0402	0.185	CbGbCtD
Triamterene—Fatigue—Lovastatin—coronary artery disease	0.000986	0.00193	CcSEcCtD
Triamterene—Thrombocytopenia—Olmesartan—coronary artery disease	0.000985	0.00193	CcSEcCtD
Triamterene—Anaphylactic shock—Niacin—coronary artery disease	0.000983	0.00192	CcSEcCtD
Triamterene—Vomiting—Gemfibrozil—coronary artery disease	0.000976	0.00191	CcSEcCtD
Triamterene—Jaundice—Lisinopril—coronary artery disease	0.000972	0.0019	CcSEcCtD
Triamterene—Asthenia—Rosuvastatin—coronary artery disease	0.000969	0.00189	CcSEcCtD
Triamterene—Rash—Gemfibrozil—coronary artery disease	0.000968	0.00189	CcSEcCtD
Triamterene—Anaphylactic shock—Pravastatin—coronary artery disease	0.000968	0.00189	CcSEcCtD
Triamterene—Fatigue—Ezetimibe—coronary artery disease	0.000968	0.00189	CcSEcCtD
Triamterene—Dermatitis—Gemfibrozil—coronary artery disease	0.000967	0.00189	CcSEcCtD
Triamterene—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.000966	0.00189	CcSEcCtD
Triamterene—Headache—Gemfibrozil—coronary artery disease	0.000962	0.00188	CcSEcCtD
Triamterene—Dry mouth—Trandolapril—coronary artery disease	0.000959	0.00188	CcSEcCtD
Triamterene—Dry mouth—Enalapril—coronary artery disease	0.000955	0.00187	CcSEcCtD
Triamterene—Vomiting—Ticagrelor—coronary artery disease	0.000954	0.00187	CcSEcCtD
Triamterene—Thrombocytopenia—Pravastatin—coronary artery disease	0.000947	0.00185	CcSEcCtD
Triamterene—Fatigue—Eplerenone—coronary artery disease	0.000947	0.00185	CcSEcCtD
Triamterene—Rash—Ticagrelor—coronary artery disease	0.000946	0.00185	CcSEcCtD
Triamterene—Dermatitis—Ticagrelor—coronary artery disease	0.000945	0.00185	CcSEcCtD
Triamterene—Dry mouth—Telmisartan—coronary artery disease	0.000942	0.00184	CcSEcCtD
Triamterene—Headache—Ticagrelor—coronary artery disease	0.00094	0.00184	CcSEcCtD
Triamterene—Anaphylactic shock—Enalapril—coronary artery disease	0.000936	0.00183	CcSEcCtD
Triamterene—Diarrhoea—Rosuvastatin—coronary artery disease	0.000924	0.00181	CcSEcCtD
Triamterene—Anaphylactic shock—Telmisartan—coronary artery disease	0.000923	0.00181	CcSEcCtD
Triamterene—Fatigue—Simvastatin—coronary artery disease	0.000923	0.00181	CcSEcCtD
Triamterene—Thrombocytopenia—Trandolapril—coronary artery disease	0.00092	0.0018	CcSEcCtD
Triamterene—Thrombocytopenia—Enalapril—coronary artery disease	0.000916	0.00179	CcSEcCtD
Triamterene—Dry mouth—Captopril—coronary artery disease	0.000916	0.00179	CcSEcCtD
Triamterene—Nausea—Gemfibrozil—coronary artery disease	0.000912	0.00178	CcSEcCtD
Triamterene—Thrombocytopenia—Telmisartan—coronary artery disease	0.000904	0.00177	CcSEcCtD
Triamterene—Anaphylactic shock—Captopril—coronary artery disease	0.000898	0.00176	CcSEcCtD
Triamterene—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000897	0.00176	CcSEcCtD
Triamterene—Dizziness—Rosuvastatin—coronary artery disease	0.000893	0.00175	CcSEcCtD
Triamterene—Nausea—Ticagrelor—coronary artery disease	0.000891	0.00174	CcSEcCtD
Triamterene—Dry mouth—Perindopril—coronary artery disease	0.000889	0.00174	CcSEcCtD
Triamterene—Thrombocytopenia—Captopril—coronary artery disease	0.000879	0.00172	CcSEcCtD
Triamterene—Anaphylactic shock—Perindopril—coronary artery disease	0.000871	0.0017	CcSEcCtD
Triamterene—Fatigue—Valsartan—coronary artery disease	0.000871	0.0017	CcSEcCtD
Triamterene—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000867	0.0017	CcSEcCtD
Triamterene—Fatigue—Olmesartan—coronary artery disease	0.000867	0.0017	CcSEcCtD
Triamterene—Dry mouth—Furosemide—coronary artery disease	0.000864	0.00169	CcSEcCtD
Triamterene—Hypersensitivity—Fenofibrate—coronary artery disease	0.000863	0.00169	CcSEcCtD
Triamterene—Thrombocytopenia—Perindopril—coronary artery disease	0.000853	0.00167	CcSEcCtD
Triamterene—Rash—Rosuvastatin—coronary artery disease	0.000851	0.00167	CcSEcCtD
Triamterene—Dermatitis—Rosuvastatin—coronary artery disease	0.000851	0.00166	CcSEcCtD
Triamterene—Hypersensitivity—Clopidogrel—coronary artery disease	0.000849	0.00166	CcSEcCtD
Triamterene—Anaphylactic shock—Furosemide—coronary artery disease	0.000847	0.00166	CcSEcCtD
Triamterene—Headache—Rosuvastatin—coronary artery disease	0.000846	0.00165	CcSEcCtD
Triamterene—Hypersensitivity—Lovastatin—coronary artery disease	0.000843	0.00165	CcSEcCtD
Triamterene—Asthenia—Fenofibrate—coronary artery disease	0.000841	0.00164	CcSEcCtD
Triamterene—Fatigue—Pravastatin—coronary artery disease	0.000834	0.00163	CcSEcCtD
Triamterene—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000834	0.00163	CcSEcCtD
Triamterene—Dry mouth—Losartan—coronary artery disease	0.000834	0.00163	CcSEcCtD
Triamterene—Thrombocytopenia—Furosemide—coronary artery disease	0.00083	0.00162	CcSEcCtD
Triamterene—Rash—Acetylsalicylic acid—coronary artery disease	0.000827	0.00162	CcSEcCtD
Triamterene—Hypersensitivity—Ezetimibe—coronary artery disease	0.000827	0.00162	CcSEcCtD
Triamterene—Asthenia—Clopidogrel—coronary artery disease	0.000826	0.00162	CcSEcCtD
Triamterene—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000826	0.00162	CcSEcCtD
Triamterene—Asthenia—Lovastatin—coronary artery disease	0.000821	0.00161	CcSEcCtD
Triamterene—Anaphylactic shock—Losartan—coronary artery disease	0.000817	0.0016	CcSEcCtD
Triamterene—Fatigue—Trandolapril—coronary artery disease	0.00081	0.00158	CcSEcCtD
Triamterene—Fatigue—Enalapril—coronary artery disease	0.000807	0.00158	CcSEcCtD
Triamterene—Asthenia—Ezetimibe—coronary artery disease	0.000805	0.00158	CcSEcCtD
Triamterene—Nausea—Rosuvastatin—coronary artery disease	0.000802	0.00157	CcSEcCtD
Triamterene—Diarrhoea—Fenofibrate—coronary artery disease	0.000802	0.00157	CcSEcCtD
Triamterene—Thrombocytopenia—Losartan—coronary artery disease	0.0008	0.00157	CcSEcCtD
Triamterene—Fatigue—Telmisartan—coronary artery disease	0.000796	0.00156	CcSEcCtD
Triamterene—Hypersensitivity—Simvastatin—coronary artery disease	0.000789	0.00154	CcSEcCtD
Triamterene—Diarrhoea—Clopidogrel—coronary artery disease	0.000788	0.00154	CcSEcCtD
Triamterene—Asthenia—Eplerenone—coronary artery disease	0.000788	0.00154	CcSEcCtD
Triamterene—Diarrhoea—Lovastatin—coronary artery disease	0.000783	0.00153	CcSEcCtD
Triamterene—Nausea—Acetylsalicylic acid—coronary artery disease	0.000779	0.00152	CcSEcCtD
Triamterene—Dizziness—Fenofibrate—coronary artery disease	0.000775	0.00152	CcSEcCtD
Triamterene—Fatigue—Captopril—coronary artery disease	0.000774	0.00151	CcSEcCtD
Triamterene—Asthenia—Simvastatin—coronary artery disease	0.000768	0.0015	CcSEcCtD
Triamterene—Diarrhoea—Ezetimibe—coronary artery disease	0.000768	0.0015	CcSEcCtD
Triamterene—Dizziness—Clopidogrel—coronary artery disease	0.000762	0.00149	CcSEcCtD
Triamterene—Dizziness—Lovastatin—coronary artery disease	0.000757	0.00148	CcSEcCtD
Triamterene—Diarrhoea—Eplerenone—coronary artery disease	0.000752	0.00147	CcSEcCtD
Triamterene—Fatigue—Perindopril—coronary artery disease	0.000751	0.00147	CcSEcCtD
Triamterene—Vomiting—Fenofibrate—coronary artery disease	0.000745	0.00146	CcSEcCtD
Triamterene—Hypersensitivity—Valsartan—coronary artery disease	0.000745	0.00146	CcSEcCtD
Triamterene—Dizziness—Ezetimibe—coronary artery disease	0.000742	0.00145	CcSEcCtD
Triamterene—Rash—Fenofibrate—coronary artery disease	0.000739	0.00145	CcSEcCtD
Triamterene—Dermatitis—Fenofibrate—coronary artery disease	0.000738	0.00144	CcSEcCtD
Triamterene—Headache—Fenofibrate—coronary artery disease	0.000734	0.00144	CcSEcCtD
Triamterene—Vomiting—Clopidogrel—coronary artery disease	0.000732	0.00143	CcSEcCtD
Triamterene—Diarrhoea—Simvastatin—coronary artery disease	0.000732	0.00143	CcSEcCtD
Triamterene—Fatigue—Furosemide—coronary artery disease	0.00073	0.00143	CcSEcCtD
Triamterene—Vomiting—Lovastatin—coronary artery disease	0.000728	0.00142	CcSEcCtD
Triamterene—Dizziness—Eplerenone—coronary artery disease	0.000726	0.00142	CcSEcCtD
Triamterene—Rash—Clopidogrel—coronary artery disease	0.000726	0.00142	CcSEcCtD
Triamterene—Dermatitis—Clopidogrel—coronary artery disease	0.000726	0.00142	CcSEcCtD
Triamterene—Asthenia—Valsartan—coronary artery disease	0.000725	0.00142	CcSEcCtD
Triamterene—Hypersensitivity—Niacin—coronary artery disease	0.000724	0.00142	CcSEcCtD
Triamterene—Asthenia—Olmesartan—coronary artery disease	0.000722	0.00141	CcSEcCtD
Triamterene—Headache—Clopidogrel—coronary artery disease	0.000722	0.00141	CcSEcCtD
Triamterene—Rash—Lovastatin—coronary artery disease	0.000721	0.00141	CcSEcCtD
Triamterene—Dermatitis—Lovastatin—coronary artery disease	0.000721	0.00141	CcSEcCtD
Triamterene—Headache—Lovastatin—coronary artery disease	0.000717	0.0014	CcSEcCtD
Triamterene—Dry mouth—Ramipril—coronary artery disease	0.000715	0.0014	CcSEcCtD
Triamterene—Vomiting—Ezetimibe—coronary artery disease	0.000714	0.0014	CcSEcCtD
Triamterene—Hypersensitivity—Pravastatin—coronary artery disease	0.000713	0.00139	CcSEcCtD
Triamterene—Dizziness—Simvastatin—coronary artery disease	0.000708	0.00138	CcSEcCtD
Triamterene—Rash—Ezetimibe—coronary artery disease	0.000708	0.00138	CcSEcCtD
Triamterene—Dermatitis—Ezetimibe—coronary artery disease	0.000707	0.00138	CcSEcCtD
Triamterene—Asthenia—Niacin—coronary artery disease	0.000705	0.00138	CcSEcCtD
Triamterene—Fatigue—Losartan—coronary artery disease	0.000705	0.00138	CcSEcCtD
Triamterene—Headache—Ezetimibe—coronary artery disease	0.000703	0.00138	CcSEcCtD
Triamterene—Anaphylactic shock—Ramipril—coronary artery disease	0.000701	0.00137	CcSEcCtD
Triamterene—Dry mouth—Timolol—coronary artery disease	0.000699	0.00137	CcSEcCtD
Triamterene—Vomiting—Eplerenone—coronary artery disease	0.000698	0.00137	CcSEcCtD
Triamterene—Nausea—Fenofibrate—coronary artery disease	0.000696	0.00136	CcSEcCtD
Triamterene—Asthenia—Pravastatin—coronary artery disease	0.000694	0.00136	CcSEcCtD
Triamterene—Rash—Eplerenone—coronary artery disease	0.000693	0.00135	CcSEcCtD
Triamterene—Hypersensitivity—Trandolapril—coronary artery disease	0.000692	0.00135	CcSEcCtD
Triamterene—Dermatitis—Eplerenone—coronary artery disease	0.000692	0.00135	CcSEcCtD
Triamterene—Diarrhoea—Valsartan—coronary artery disease	0.000692	0.00135	CcSEcCtD
Triamterene—Hypersensitivity—Enalapril—coronary artery disease	0.00069	0.00135	CcSEcCtD
Triamterene—Diarrhoea—Olmesartan—coronary artery disease	0.000688	0.00135	CcSEcCtD
Triamterene—Headache—Eplerenone—coronary artery disease	0.000688	0.00135	CcSEcCtD
Triamterene—Thrombocytopenia—Ramipril—coronary artery disease	0.000686	0.00134	CcSEcCtD
Triamterene—Anaphylactic shock—Timolol—coronary artery disease	0.000685	0.00134	CcSEcCtD
Triamterene—Nausea—Clopidogrel—coronary artery disease	0.000684	0.00134	CcSEcCtD
Triamterene—Vomiting—Simvastatin—coronary artery disease	0.00068	0.00133	CcSEcCtD
Triamterene—Hypersensitivity—Telmisartan—coronary artery disease	0.00068	0.00133	CcSEcCtD
Triamterene—Nausea—Lovastatin—coronary artery disease	0.00068	0.00133	CcSEcCtD
Triamterene—Rash—Simvastatin—coronary artery disease	0.000675	0.00132	CcSEcCtD
Triamterene—Dermatitis—Simvastatin—coronary artery disease	0.000674	0.00132	CcSEcCtD
Triamterene—Asthenia—Trandolapril—coronary artery disease	0.000674	0.00132	CcSEcCtD
Triamterene—Diarrhoea—Niacin—coronary artery disease	0.000672	0.00132	CcSEcCtD
Triamterene—Asthenia—Enalapril—coronary artery disease	0.000671	0.00131	CcSEcCtD
Triamterene—Headache—Simvastatin—coronary artery disease	0.00067	0.00131	CcSEcCtD
Triamterene—Dizziness—Valsartan—coronary artery disease	0.000668	0.00131	CcSEcCtD
Triamterene—Nausea—Ezetimibe—coronary artery disease	0.000667	0.0013	CcSEcCtD
Triamterene—Dizziness—Olmesartan—coronary artery disease	0.000665	0.0013	CcSEcCtD
Triamterene—Asthenia—Telmisartan—coronary artery disease	0.000662	0.0013	CcSEcCtD
Triamterene—Diarrhoea—Pravastatin—coronary artery disease	0.000662	0.0013	CcSEcCtD
Triamterene—Nausea—Eplerenone—coronary artery disease	0.000652	0.00128	CcSEcCtD
Triamterene—Dizziness—Niacin—coronary artery disease	0.00065	0.00127	CcSEcCtD
Triamterene—Dry mouth—Lisinopril—coronary artery disease	0.000649	0.00127	CcSEcCtD
Triamterene—Asthenia—Captopril—coronary artery disease	0.000644	0.00126	CcSEcCtD
Triamterene—Diarrhoea—Trandolapril—coronary artery disease	0.000643	0.00126	CcSEcCtD
Triamterene—Vomiting—Valsartan—coronary artery disease	0.000643	0.00126	CcSEcCtD
Triamterene—Diarrhoea—Enalapril—coronary artery disease	0.00064	0.00125	CcSEcCtD
Triamterene—Dizziness—Pravastatin—coronary artery disease	0.00064	0.00125	CcSEcCtD
Triamterene—Vomiting—Olmesartan—coronary artery disease	0.00064	0.00125	CcSEcCtD
Triamterene—Rash—Valsartan—coronary artery disease	0.000637	0.00125	CcSEcCtD
Triamterene—Dermatitis—Valsartan—coronary artery disease	0.000637	0.00125	CcSEcCtD
Triamterene—Nausea—Simvastatin—coronary artery disease	0.000636	0.00124	CcSEcCtD
Triamterene—Anaphylactic shock—Lisinopril—coronary artery disease	0.000636	0.00124	CcSEcCtD
Triamterene—Rash—Olmesartan—coronary artery disease	0.000634	0.00124	CcSEcCtD
Triamterene—Dermatitis—Olmesartan—coronary artery disease	0.000634	0.00124	CcSEcCtD
Triamterene—Headache—Valsartan—coronary artery disease	0.000633	0.00124	CcSEcCtD
Triamterene—Diarrhoea—Telmisartan—coronary artery disease	0.000632	0.00124	CcSEcCtD
Triamterene—Headache—Olmesartan—coronary artery disease	0.00063	0.00123	CcSEcCtD
Triamterene—Asthenia—Perindopril—coronary artery disease	0.000625	0.00122	CcSEcCtD
Triamterene—Vomiting—Niacin—coronary artery disease	0.000625	0.00122	CcSEcCtD
Triamterene—Hypersensitivity—Furosemide—coronary artery disease	0.000624	0.00122	CcSEcCtD
Triamterene—Thrombocytopenia—Lisinopril—coronary artery disease	0.000622	0.00122	CcSEcCtD
Triamterene—Dizziness—Trandolapril—coronary artery disease	0.000621	0.00122	CcSEcCtD
Triamterene—Rash—Niacin—coronary artery disease	0.00062	0.00121	CcSEcCtD
Triamterene—Dermatitis—Niacin—coronary artery disease	0.000619	0.00121	CcSEcCtD
Triamterene—Dizziness—Enalapril—coronary artery disease	0.000619	0.00121	CcSEcCtD
Triamterene—Headache—Niacin—coronary artery disease	0.000616	0.0012	CcSEcCtD
Triamterene—Vomiting—Pravastatin—coronary artery disease	0.000615	0.0012	CcSEcCtD
Triamterene—Diarrhoea—Captopril—coronary artery disease	0.000614	0.0012	CcSEcCtD
Triamterene—Dizziness—Telmisartan—coronary artery disease	0.00061	0.00119	CcSEcCtD
Triamterene—Rash—Pravastatin—coronary artery disease	0.00061	0.00119	CcSEcCtD
Triamterene—Dermatitis—Pravastatin—coronary artery disease	0.00061	0.00119	CcSEcCtD
Triamterene—Asthenia—Furosemide—coronary artery disease	0.000608	0.00119	CcSEcCtD
Triamterene—Headache—Pravastatin—coronary artery disease	0.000606	0.00119	CcSEcCtD
Triamterene—Fatigue—Ramipril—coronary artery disease	0.000604	0.00118	CcSEcCtD
Triamterene—Hypersensitivity—Losartan—coronary artery disease	0.000602	0.00118	CcSEcCtD
Triamterene—Nausea—Valsartan—coronary artery disease	0.0006	0.00117	CcSEcCtD
Triamterene—Nausea—Olmesartan—coronary artery disease	0.000597	0.00117	CcSEcCtD
Triamterene—Vomiting—Trandolapril—coronary artery disease	0.000597	0.00117	CcSEcCtD
Triamterene—Diarrhoea—Perindopril—coronary artery disease	0.000596	0.00117	CcSEcCtD
Triamterene—Vomiting—Enalapril—coronary artery disease	0.000595	0.00116	CcSEcCtD
Triamterene—Dizziness—Captopril—coronary artery disease	0.000594	0.00116	CcSEcCtD
Triamterene—Rash—Trandolapril—coronary artery disease	0.000592	0.00116	CcSEcCtD
Triamterene—Dermatitis—Trandolapril—coronary artery disease	0.000592	0.00116	CcSEcCtD
Triamterene—Fatigue—Timolol—coronary artery disease	0.000591	0.00116	CcSEcCtD
Triamterene—Rash—Enalapril—coronary artery disease	0.00059	0.00115	CcSEcCtD
Triamterene—Dermatitis—Enalapril—coronary artery disease	0.00059	0.00115	CcSEcCtD
Triamterene—Headache—Trandolapril—coronary artery disease	0.000589	0.00115	CcSEcCtD
Triamterene—Vomiting—Telmisartan—coronary artery disease	0.000587	0.00115	CcSEcCtD
Triamterene—Asthenia—Losartan—coronary artery disease	0.000586	0.00115	CcSEcCtD
Triamterene—Headache—Enalapril—coronary artery disease	0.000586	0.00115	CcSEcCtD
Triamterene—Nausea—Niacin—coronary artery disease	0.000584	0.00114	CcSEcCtD
Triamterene—Rash—Telmisartan—coronary artery disease	0.000582	0.00114	CcSEcCtD
Triamterene—Dermatitis—Telmisartan—coronary artery disease	0.000581	0.00114	CcSEcCtD
Triamterene—Diarrhoea—Furosemide—coronary artery disease	0.00058	0.00113	CcSEcCtD
Triamterene—Headache—Telmisartan—coronary artery disease	0.000578	0.00113	CcSEcCtD
Triamterene—Dizziness—Perindopril—coronary artery disease	0.000576	0.00113	CcSEcCtD
Triamterene—Nausea—Pravastatin—coronary artery disease	0.000575	0.00112	CcSEcCtD
Triamterene—Vomiting—Captopril—coronary artery disease	0.000571	0.00112	CcSEcCtD
Triamterene—Rash—Captopril—coronary artery disease	0.000566	0.00111	CcSEcCtD
Triamterene—Dermatitis—Captopril—coronary artery disease	0.000565	0.00111	CcSEcCtD
Triamterene—Headache—Captopril—coronary artery disease	0.000562	0.0011	CcSEcCtD
Triamterene—Dizziness—Furosemide—coronary artery disease	0.00056	0.0011	CcSEcCtD
Triamterene—Diarrhoea—Losartan—coronary artery disease	0.000559	0.00109	CcSEcCtD
Triamterene—Nausea—Trandolapril—coronary artery disease	0.000558	0.00109	CcSEcCtD
Triamterene—Nausea—Enalapril—coronary artery disease	0.000556	0.00109	CcSEcCtD
Triamterene—Vomiting—Perindopril—coronary artery disease	0.000554	0.00108	CcSEcCtD
Triamterene—Rash—Perindopril—coronary artery disease	0.000549	0.00107	CcSEcCtD
Triamterene—Dermatitis—Perindopril—coronary artery disease	0.000549	0.00107	CcSEcCtD
Triamterene—Nausea—Telmisartan—coronary artery disease	0.000548	0.00107	CcSEcCtD
Triamterene—Fatigue—Lisinopril—coronary artery disease	0.000548	0.00107	CcSEcCtD
Triamterene—CYP1A2—Phase II conjugation—SULT4A1—coronary artery disease	0.000548	0.00202	CbGpPWpGaD
Triamterene—Headache—Perindopril—coronary artery disease	0.000546	0.00107	CcSEcCtD
Triamterene—CYP1A2—Aflatoxin activation and detoxification—GGT1—coronary artery disease	0.000545	0.00201	CbGpPWpGaD
Triamterene—Dizziness—Losartan—coronary artery disease	0.000541	0.00106	CcSEcCtD
Triamterene—Vomiting—Furosemide—coronary artery disease	0.000539	0.00105	CcSEcCtD
Triamterene—Rash—Furosemide—coronary artery disease	0.000534	0.00104	CcSEcCtD
Triamterene—Dermatitis—Furosemide—coronary artery disease	0.000534	0.00104	CcSEcCtD
Triamterene—Nausea—Captopril—coronary artery disease	0.000533	0.00104	CcSEcCtD
Triamterene—Headache—Furosemide—coronary artery disease	0.000531	0.00104	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000527	0.00194	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000527	0.00194	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000527	0.00194	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000527	0.00194	CbGpPWpGaD
Triamterene—Vomiting—Losartan—coronary artery disease	0.00052	0.00102	CcSEcCtD
Triamterene—Nausea—Perindopril—coronary artery disease	0.000518	0.00101	CcSEcCtD
Triamterene—Hypersensitivity—Ramipril—coronary artery disease	0.000516	0.00101	CcSEcCtD
Triamterene—CYP1A2—Melatonin metabolism and effects—CYP2C19—coronary artery disease	0.000516	0.0019	CbGpPWpGaD
Triamterene—Rash—Losartan—coronary artery disease	0.000515	0.00101	CcSEcCtD
Triamterene—Dermatitis—Losartan—coronary artery disease	0.000515	0.00101	CcSEcCtD
Triamterene—Headache—Losartan—coronary artery disease	0.000512	0.001	CcSEcCtD
Triamterene—Hypersensitivity—Timolol—coronary artery disease	0.000505	0.000988	CcSEcCtD
Triamterene—Nausea—Furosemide—coronary artery disease	0.000503	0.000984	CcSEcCtD
Triamterene—Asthenia—Ramipril—coronary artery disease	0.000503	0.000984	CcSEcCtD
Triamterene—CYP1A2—Tryptophan metabolism—HADH—coronary artery disease	0.000497	0.00183	CbGpPWpGaD
Triamterene—Asthenia—Timolol—coronary artery disease	0.000492	0.000962	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.000486	0.00179	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.000486	0.00179	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.000486	0.00179	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.000486	0.00179	CbGpPWpGaD
Triamterene—Nausea—Losartan—coronary artery disease	0.000486	0.00095	CcSEcCtD
Triamterene—Diarrhoea—Ramipril—coronary artery disease	0.00048	0.000938	CcSEcCtD
Triamterene—CYP1A2—Estrogen Receptor Pathway—ESR1—coronary artery disease	0.000479	0.00177	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen metabolism—GSTM1—coronary artery disease	0.00047	0.00173	CbGpPWpGaD
Triamterene—Diarrhoea—Timolol—coronary artery disease	0.000469	0.000917	CcSEcCtD
Triamterene—Hypersensitivity—Lisinopril—coronary artery disease	0.000468	0.000916	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—APOB—coronary artery disease	0.000466	0.00172	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—APOB—coronary artery disease	0.000466	0.00172	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—APOB—coronary artery disease	0.000466	0.00172	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—APOB—coronary artery disease	0.000466	0.00172	CbGpPWpGaD
Triamterene—Dizziness—Ramipril—coronary artery disease	0.000463	0.000907	CcSEcCtD
Triamterene—Asthenia—Lisinopril—coronary artery disease	0.000456	0.000892	CcSEcCtD
Triamterene—Dizziness—Timolol—coronary artery disease	0.000453	0.000886	CcSEcCtD
Triamterene—CYP1A2—Melatonin metabolism and effects—ADRB1—coronary artery disease	0.000448	0.00165	CbGpPWpGaD
Triamterene—Vomiting—Ramipril—coronary artery disease	0.000446	0.000872	CcSEcCtD
Triamterene—Rash—Ramipril—coronary artery disease	0.000442	0.000865	CcSEcCtD
Triamterene—Dermatitis—Ramipril—coronary artery disease	0.000442	0.000864	CcSEcCtD
Triamterene—CYP1A2—Arachidonic acid metabolism—GPX2—coronary artery disease	0.000441	0.00162	CbGpPWpGaD
Triamterene—Headache—Ramipril—coronary artery disease	0.000439	0.000859	CcSEcCtD
Triamterene—Vomiting—Timolol—coronary artery disease	0.000436	0.000852	CcSEcCtD
Triamterene—CYP1A2—Arachidonic acid metabolism—GPX4—coronary artery disease	0.000435	0.00161	CbGpPWpGaD
Triamterene—Diarrhoea—Lisinopril—coronary artery disease	0.000435	0.000851	CcSEcCtD
Triamterene—Rash—Timolol—coronary artery disease	0.000432	0.000845	CcSEcCtD
Triamterene—Dermatitis—Timolol—coronary artery disease	0.000432	0.000844	CcSEcCtD
Triamterene—Headache—Timolol—coronary artery disease	0.000429	0.00084	CcSEcCtD
Triamterene—Dizziness—Lisinopril—coronary artery disease	0.00042	0.000822	CcSEcCtD
Triamterene—Nausea—Ramipril—coronary artery disease	0.000416	0.000814	CcSEcCtD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11B2—coronary artery disease	0.000414	0.00153	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP11B2—coronary artery disease	0.000408	0.00151	CbGpPWpGaD
Triamterene—Nausea—Timolol—coronary artery disease	0.000407	0.000796	CcSEcCtD
Triamterene—Vomiting—Lisinopril—coronary artery disease	0.000404	0.000791	CcSEcCtD
Triamterene—Rash—Lisinopril—coronary artery disease	0.000401	0.000784	CcSEcCtD
Triamterene—Dermatitis—Lisinopril—coronary artery disease	0.0004	0.000783	CcSEcCtD
Triamterene—Headache—Lisinopril—coronary artery disease	0.000398	0.000779	CcSEcCtD
Triamterene—CYP1A2—Phase II conjugation—GSTM2—coronary artery disease	0.00039	0.00144	CbGpPWpGaD
Triamterene—Nausea—Lisinopril—coronary artery disease	0.000378	0.000739	CcSEcCtD
Triamterene—CYP1A2—Phase II conjugation—SULT1E1—coronary artery disease	0.00037	0.00136	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—APOA1—coronary artery disease	0.000369	0.00136	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—APOA1—coronary artery disease	0.000369	0.00136	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—APOA1—coronary artery disease	0.000369	0.00136	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—APOA1—coronary artery disease	0.000369	0.00136	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—ALDH2—coronary artery disease	0.000366	0.00135	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—coronary artery disease	0.000354	0.0013	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—coronary artery disease	0.000344	0.00127	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP11B2—coronary artery disease	0.000335	0.00124	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—CYP2C19—coronary artery disease	0.000334	0.00123	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—EDN1—coronary artery disease	0.000325	0.0012	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—SULT4A1—coronary artery disease	0.00032	0.00118	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—SULT4A1—coronary artery disease	0.000316	0.00117	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GCLM—coronary artery disease	0.000314	0.00116	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ALB—coronary artery disease	0.000292	0.00108	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ALB—coronary artery disease	0.000292	0.00108	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ALB—coronary artery disease	0.000292	0.00108	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ALB—coronary artery disease	0.000292	0.00108	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C19—coronary artery disease	0.000289	0.00106	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—coronary artery disease	0.000287	0.00106	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP2C19—coronary artery disease	0.000285	0.00105	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—SULT1A1—coronary artery disease	0.000277	0.00102	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTA1—coronary artery disease	0.00027	0.000997	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—APOE—coronary artery disease	0.000264	0.000974	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—GGT1—coronary artery disease	0.000251	0.000928	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—coronary artery disease	0.00024	0.000885	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CAT—coronary artery disease	0.000235	0.000867	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C19—coronary artery disease	0.000234	0.000863	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—GSK3B—coronary artery disease	0.000229	0.000843	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTM2—coronary artery disease	0.000228	0.000842	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTM2—coronary artery disease	0.000225	0.00083	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—LPL—coronary artery disease	0.000218	0.000803	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—SULT1E1—coronary artery disease	0.000216	0.000798	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—coronary artery disease	0.000216	0.000798	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—SULT1E1—coronary artery disease	0.000213	0.000787	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTT1—coronary artery disease	0.000207	0.000765	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CD36—coronary artery disease	0.000207	0.000763	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GCLC—coronary artery disease	0.000205	0.000756	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—AKR1B1—coronary artery disease	0.000204	0.000751	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	0.000203	0.000747	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—GPX1—coronary artery disease	0.000199	0.000733	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GCLM—coronary artery disease	0.000184	0.000679	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP11B2—coronary artery disease	0.000178	0.000657	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP11B2—coronary artery disease	0.000176	0.000648	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—coronary artery disease	0.000174	0.000643	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—SULT1A1—coronary artery disease	0.000162	0.000597	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GPX2—coronary artery disease	0.000162	0.000596	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GGT1—coronary artery disease	0.00016	0.00059	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GPX4—coronary artery disease	0.00016	0.000589	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—SULT1A1—coronary artery disease	0.00016	0.000589	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTA1—coronary artery disease	0.000158	0.000583	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTP1—coronary artery disease	0.000144	0.00053	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPAP2B—coronary artery disease	0.000132	0.000488	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTM1—coronary artery disease	0.000132	0.000487	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GPX3—coronary artery disease	0.000131	0.000484	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—ALDH2—coronary artery disease	0.000128	0.00047	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	0.000127	0.000468	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—coronary artery disease	0.000125	0.000461	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2C19—coronary artery disease	0.000124	0.000458	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2C19—coronary artery disease	0.000123	0.000452	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTT1—coronary artery disease	0.000121	0.000447	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GCLC—coronary artery disease	0.00012	0.000442	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—PTGS2—coronary artery disease	0.000117	0.000432	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—coronary artery disease	0.000116	0.000429	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HMGCS2—coronary artery disease	0.00011	0.000404	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GK—coronary artery disease	0.00011	0.000404	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	0.000103	0.000379	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—UGCG—coronary artery disease	0.0001	0.00037	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—coronary artery disease	9.85e-05	0.000363	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GGT1—coronary artery disease	9.36e-05	0.000345	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—coronary artery disease	9.04e-05	0.000334	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—coronary artery disease	8.87e-05	0.000327	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PLIN1—coronary artery disease	8.76e-05	0.000323	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CA5B—coronary artery disease	8.5e-05	0.000314	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—coronary artery disease	8.45e-05	0.000311	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—coronary artery disease	8.45e-05	0.000311	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTP1—coronary artery disease	8.41e-05	0.00031	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTP1—coronary artery disease	8.29e-05	0.000306	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—coronary artery disease	7.93e-05	0.000292	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTM1—coronary artery disease	7.73e-05	0.000285	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTM1—coronary artery disease	7.62e-05	0.000281	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SLC27A1—coronary artery disease	7.6e-05	0.00028	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—coronary artery disease	7.45e-05	0.000275	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—coronary artery disease	7.45e-05	0.000275	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—coronary artery disease	7.31e-05	0.00027	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CKMT1B—coronary artery disease	7.23e-05	0.000267	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	6.84e-05	0.000252	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—coronary artery disease	6.84e-05	0.000252	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	6.64e-05	0.000245	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	6.64e-05	0.000245	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	6.3e-05	0.000232	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	6.3e-05	0.000232	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	6.3e-05	0.000232	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	6.22e-05	0.000229	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	6.22e-05	0.000229	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	6.15e-05	0.000227	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	6.01e-05	0.000222	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CKM—coronary artery disease	5.89e-05	0.000217	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPAP2B—coronary artery disease	5.89e-05	0.000217	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UQCRFS1—coronary artery disease	5.89e-05	0.000217	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	5.76e-05	0.000212	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	5.65e-05	0.000208	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	5.54e-05	0.000204	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PDK4—coronary artery disease	5.48e-05	0.000202	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALDH6A1—coronary artery disease	5.48e-05	0.000202	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CKMT2—coronary artery disease	5.48e-05	0.000202	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SULT4A1—coronary artery disease	5.48e-05	0.000202	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PYGM—coronary artery disease	5.48e-05	0.000202	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—POMC—coronary artery disease	5.46e-05	0.000201	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PFKM—coronary artery disease	4.88e-05	0.00018	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LDHA—coronary artery disease	4.88e-05	0.00018	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GK—coronary artery disease	4.88e-05	0.00018	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GYG1—coronary artery disease	4.88e-05	0.00018	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMGCS2—coronary artery disease	4.88e-05	0.00018	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GATM—coronary artery disease	4.88e-05	0.00018	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	4.77e-05	0.000176	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	4.77e-05	0.000176	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	4.77e-05	0.000176	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	4.74e-05	0.000175	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	4.71e-05	0.000174	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GCH1—coronary artery disease	4.66e-05	0.000172	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AK1—coronary artery disease	4.66e-05	0.000172	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	4.6e-05	0.00017	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	4.55e-05	0.000168	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLCD1—coronary artery disease	4.47e-05	0.000165	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPAT—coronary artery disease	4.47e-05	0.000165	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UGCG—coronary artery disease	4.47e-05	0.000165	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MDH2—coronary artery disease	4.47e-05	0.000165	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PGM1—coronary artery disease	4.3e-05	0.000159	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	4.2e-05	0.000155	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	4.16e-05	0.000154	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PYGB—coronary artery disease	4.15e-05	0.000153	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CKB—coronary artery disease	4.15e-05	0.000153	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—COX5B—coronary artery disease	3.9e-05	0.000144	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLIN1—coronary artery disease	3.9e-05	0.000144	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PFKFB3—coronary artery disease	3.9e-05	0.000144	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTM2—coronary artery disease	3.9e-05	0.000144	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—DLAT—coronary artery disease	3.9e-05	0.000144	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	3.71e-05	0.000137	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SULT1E1—coronary artery disease	3.7e-05	0.000136	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	3.59e-05	0.000133	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HK2—coronary artery disease	3.53e-05	0.00013	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AKR1B1—coronary artery disease	3.53e-05	0.00013	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC27A1—coronary artery disease	3.38e-05	0.000125	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CPT1B—coronary artery disease	3.32e-05	0.000122	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LCAT—coronary artery disease	3.32e-05	0.000122	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOA4—coronary artery disease	3.26e-05	0.00012	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	3.2e-05	0.000118	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PDHA1—coronary artery disease	3.15e-05	0.000116	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GCLM—coronary artery disease	3.15e-05	0.000116	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	3.05e-05	0.000112	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP11B2—coronary artery disease	3.05e-05	0.000112	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TXNRD1—coronary artery disease	3.05e-05	0.000112	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC22A3—coronary artery disease	3e-05	0.000111	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HADH—coronary artery disease	2.96e-05	0.000109	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ARNTL—coronary artery disease	2.96e-05	0.000109	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	2.91e-05	0.000107	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	2.84e-05	0.000105	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	2.8e-05	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPX2—coronary artery disease	2.8e-05	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOA2—coronary artery disease	2.8e-05	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SULT1A1—coronary artery disease	2.77e-05	0.000102	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HK1—coronary artery disease	2.77e-05	0.000102	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPX4—coronary artery disease	2.77e-05	0.000102	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCG5—coronary artery disease	2.77e-05	0.000102	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	2.77e-05	0.000102	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HADHA—coronary artery disease	2.74e-05	0.000101	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTA1—coronary artery disease	2.71e-05	9.98e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LPA—coronary artery disease	2.68e-05	9.87e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLCB3—coronary artery disease	2.59e-05	9.56e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOA5—coronary artery disease	2.56e-05	9.46e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—P4HB—coronary artery disease	2.52e-05	9.28e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	2.49e-05	9.19e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	2.47e-05	9.11e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	2.44e-05	9e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	2.41e-05	8.9e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—VCAN—coronary artery disease	2.33e-05	8.58e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALDOA—coronary artery disease	2.31e-05	8.52e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—DCN—coronary artery disease	2.24e-05	8.27e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALDH2—coronary artery disease	2.18e-05	8.04e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.13e-05	7.84e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LIPC—coronary artery disease	2.13e-05	7.84e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	2.13e-05	7.84e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HBA1—coronary artery disease	2.13e-05	7.84e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2C19—coronary artery disease	2.13e-05	7.84e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOC3—coronary artery disease	2.11e-05	7.79e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LDLR—coronary artery disease	2.1e-05	7.74e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.1e-05	7.73e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC9A1—coronary artery disease	2.07e-05	7.65e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTT1—coronary artery disease	2.07e-05	7.65e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CETP—coronary artery disease	2.05e-05	7.56e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GCLC—coronary artery disease	2.05e-05	7.56e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SDC1—coronary artery disease	2.03e-05	7.48e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PSMA6—coronary artery disease	1.92e-05	7.06e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PSMB5—coronary artery disease	1.92e-05	7.06e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.91e-05	7.05e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CTGF—coronary artery disease	1.87e-05	6.9e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMGCR—coronary artery disease	1.85e-05	6.84e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GOT2—coronary artery disease	1.85e-05	6.84e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLCB1—coronary artery disease	1.71e-05	6.29e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.67e-05	6.17e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCA1—coronary artery disease	1.65e-05	6.1e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GOT1—coronary artery disease	1.6e-05	5.9e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GGT1—coronary artery disease	1.6e-05	5.9e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.44e-05	5.3e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.42e-05	5.25e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.42e-05	5.23e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CAT—coronary artery disease	1.4e-05	5.16e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOB—coronary artery disease	1.36e-05	5.01e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.32e-05	4.87e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LPL—coronary artery disease	1.3e-05	4.78e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPX1—coronary artery disease	1.27e-05	4.67e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CD36—coronary artery disease	1.23e-05	4.54e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.22e-05	4.49e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.17e-05	4.31e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AGT—coronary artery disease	1.11e-05	4.09e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOE—coronary artery disease	1.09e-05	4.01e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOA1—coronary artery disease	1.07e-05	3.96e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.03e-05	3.8e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPARG—coronary artery disease	9.47e-06	3.49e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—POMC—coronary artery disease	9.34e-06	3.44e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALB—coronary artery disease	8.51e-06	3.14e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NOS3—coronary artery disease	8.14e-06	3e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGS2—coronary artery disease	7.45e-06	2.75e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CA—coronary artery disease	4.58e-06	1.69e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AKT1—coronary artery disease	3.74e-06	1.38e-05	CbGpPWpGaD
